More than two thirds of people with ADHD have at least one co-occurring condition. Understanding these related conditions is essential for accurate diagnosis and effective treatment.
ADHD is frequently accompanied by one or more co-occurring conditions, also known as comorbidities. Research consistently shows that more than two thirds of individuals with ADHD have at least one other diagnosable condition, and up to 80% of adults with ADHD report having at least one other mental health challenge. This high rate of co-occurrence is not coincidental — it reflects shared neurological, genetic, and environmental factors that increase vulnerability across multiple conditions.
Understanding which conditions commonly co-occur with ADHD is important for several reasons. Co-occurring conditions can mask ADHD symptoms, making diagnosis harder. They can worsen the impact of ADHD on daily life. They can respond differently to standard ADHD treatments. And in some cases, treating the co-occurring condition first actually improves ADHD-related difficulties as well.
This page covers the full range of conditions most commonly associated with ADHD, from anxiety and depression to learning disabilities, autism, sleep disorders, and beyond.
Important: Co-occurring conditions can mimic ADHD symptoms, and ADHD symptoms can mimic co-occurring conditions. This overlap makes careful, comprehensive clinical assessment essential. A diagnosis of one condition should not automatically exclude assessment for others.
Mental health conditions are among the most common co-occurring conditions in people with ADHD. They can develop as a direct consequence of living with undiagnosed or undertreated ADHD, or share underlying neurological and genetic risk factors with ADHD itself.
Anxiety disorders are among the most frequently co-occurring conditions with ADHD. Up to 30% of children and up to 53% of adults with ADHD also have an anxiety disorder. The constant demands of managing ADHD symptoms, fear of failure, rejection sensitivity, and chronic overwhelm all contribute to elevated anxiety in people with ADHD.
Types of anxiety that commonly co-occur with ADHD include:
Standard ADHD stimulant medication can worsen anxiety in some patients. Non-stimulant options or combined approaches are often necessary when anxiety is a significant co-occurring feature.
Oppositional defiant disorder is one of the most common conditions found alongside ADHD, occurring in approximately 40% of individuals with ADHD. ODD involves a persistent pattern of angry, irritable mood, argumentative or defiant behaviour, and vindictiveness that causes significant problems at home, school, and in relationships.
Characteristic behaviours include:
ODD typically begins before the age of 8 and is most pronounced around familiar adults such as parents and regular caregivers. Early behavioural intervention is the most effective treatment approach.
Conduct disorder occurs in approximately 27% of children, 45 to 50% of adolescents, and 20 to 25% of adults with ADHD. It is a more severe behavioural disorder involving persistent aggression, destruction of property, deceitfulness, and serious violations of social rules and laws.
Early identification and comprehensive treatment combining medication, behavioural therapy, family support, and school intervention are critical. Untreated conduct disorder significantly worsens long-term outcomes.
OCD is characterised by intrusive, unwanted thoughts (obsessions) and repetitive behaviours or mental acts performed to reduce anxiety (compulsions). While OCD and ADHD are distinct conditions, they co-occur more frequently than chance would predict, and their symptoms can overlap significantly, particularly around difficulty shifting attention, perfectionism, and emotional regulation.
Careful differential diagnosis is important as some ADHD treatments can exacerbate OCD symptoms, and vice versa. Cognitive behavioural therapy with exposure and response prevention (ERP) is the gold standard treatment for OCD.
Rejection Sensitive Dysphoria is an intense emotional response to perceived or actual failure, criticism, or social rejection that is significantly more extreme than typical emotional reactions. While not a formally recognised DSM-5 diagnosis, RSD is widely reported by people with ADHD and is considered by many clinicians to be one of the most impairing aspects of the condition.
Mood disorders are significantly more prevalent in people with ADHD than in the general population. Approximately 38% of adults with ADHD have a co-occurring mood disorder. The relationship is often bidirectional — ADHD can contribute to the development of depression and mood instability, and mood disorders can worsen ADHD-related executive function difficulties.
Depression co-occurs with ADHD at a significantly elevated rate. Approximately 14% of children with ADHD also have depression, compared with only 1% of children without ADHD. In adults, the figure rises to approximately 47%. ADHD typically precedes depression in the timeline, with depression often developing as a secondary consequence of years of struggling with undiagnosed or unmanaged ADHD symptoms, academic or professional underachievement, relationship difficulties, and chronic shame.
Treating ADHD effectively often improves depressive symptoms by addressing the underlying source of chronic failure and frustration. However, depression frequently requires its own targeted treatment alongside ADHD management.
Up to 20% of individuals with ADHD may show symptoms of bipolar disorder, a serious condition involving episodes of mania (abnormally elevated mood, energy, and activity) contrasted with episodes of clinical depression. The overlap between ADHD and bipolar disorder is significant and the differential diagnosis can be challenging, as both conditions involve impulsivity, distractibility, restlessness, and emotional dysregulation.
Careful differential diagnosis is essential. Stimulant medications used for ADHD can trigger manic episodes in individuals with undiagnosed bipolar disorder. Mood stabilisers are typically introduced before stimulants in patients with both conditions.
Dysthymia, now classified as persistent depressive disorder, involves chronic low-level depression lasting for at least two years. People with ADHD who have not been diagnosed or effectively treated often develop a persistent background of low mood, low self-esteem, and negative self-talk as a result of chronic underachievement and the cumulative impact of living with ADHD without adequate support.
ADHD frequently co-occurs with other neurodevelopmental conditions, reflecting shared genetic and neurological underpinnings. These conditions often interact with each other, compounding their individual effects on learning, behaviour, and daily functioning.
Up to 50% of children with ADHD have a co-occurring learning disorder, compared with only 5% of children without ADHD. The combination creates particular challenges in educational settings and requires careful identification of each condition to ensure appropriate support is provided.
Additionally, approximately 12% of children with ADHD have speech and language difficulties, compared with 3% of children without ADHD. Each learning disability requires specialised educational support alongside ADHD management.
ADHD and autism spectrum disorder (ASD) frequently co-occur and share multiple overlapping features including difficulties with executive function, sensory sensitivity, social communication challenges, and emotional regulation. Until 2013, the DSM did not allow both diagnoses to be made simultaneously. Research now consistently shows they are distinct but commonly co-occurring conditions.
The term AuDHD is increasingly used within the neurodivergent community to describe the experience of having both conditions. Diagnosis and treatment planning for AuDHD requires specialist expertise in both conditions.
Less than 10% of individuals with ADHD have tics or Tourette Syndrome. However, the relationship is strongly asymmetric: between 60 and 80% of those with Tourette Syndrome also have ADHD. Tics are sudden, rapid, recurrent, involuntary movements or vocalisations. Tourette Syndrome is a more severe and persistent tic disorder involving multiple motor tics and at least one vocal tic present for more than a year.
Developmental coordination disorder, sometimes known as dyspraxia, involves significant difficulties with motor coordination and physical skill acquisition that impact daily activities. DCD co-occurs with ADHD more frequently than chance would predict, and the combination can significantly affect a child's physical confidence, participation in sport and PE, and fine motor tasks such as handwriting.
The co-occurring conditions associated with ADHD extend beyond mental health and neurodevelopmental conditions to include a range of physical and sleep-related challenges that are significantly more prevalent in people with ADHD than in the general population.
Sleep difficulties are extremely common in people with ADHD. Between a quarter and a half of parents of children with ADHD report that their child has significant sleep problems. Sleep disorders in ADHD may be a direct symptom of the condition, may be worsened by ADHD, or may worsen ADHD symptoms, creating a compounding negative cycle.
Sleep hygiene interventions, melatonin, and in some cases adjusting the timing of ADHD medication can all contribute to improved sleep in people with ADHD.
Restless leg syndrome, an uncomfortable urge to move the legs typically worsening in the evening and at night, affects up to 33% of adults with ADHD. The two conditions share common neurological pathways involving dopamine dysregulation, which may explain their frequent co-occurrence. RLS significantly disrupts sleep quality and can worsen daytime ADHD symptoms.
People with ADHD are at significantly elevated risk of developing substance use disorders. Research shows that adolescents with ADHD are twice as likely to become addicted to nicotine as those without the condition, and are more likely to progress to alcohol and drug use at an earlier age. Adults with ADHD have elevated rates of smoking and report particular difficulty quitting.
Importantly, research shows that adolescents with ADHD who are treated with stimulant medication are actually less likely to subsequently use illegal drugs than those with ADHD who are not receiving treatment.
Adults and children with ADHD have a higher likelihood of obesity and disordered eating patterns. Several ADHD-related factors contribute, including impulsive eating, poor planning of meals, binge eating episodes, difficulty with routine, and reward-seeking behaviour. Some research also suggests that ADHD-related dopamine dysregulation affects appetite regulation and food reward processing.
Research has identified a number of other physical health associations that appear more frequently in people with ADHD than in the general population. While the evidence base for some of these is still emerging, they are worth noting as part of a comprehensive understanding of how ADHD can interact with overall health.
The table below provides a concise overview of the prevalence of the most common conditions co-occurring with ADHD.
| Condition | Prevalence in ADHD | Category | Key Consideration |
|---|---|---|---|
| Anxiety Disorders | 30% children, 53% adults | Mental health | Stimulants may worsen anxiety |
| Depression | 14% children, 47% adults | Mood disorder | ADHD typically precedes depression |
| Oppositional Defiant Disorder | ~40% | Behavioural | Most common co-occurring disorder |
| Conduct Disorder | 27% children, 20–25% adults | Behavioural | Increases risk of legal issues |
| Learning Disabilities | Up to 50% of children | Neurodevelopmental | Dyslexia most common |
| Autism Spectrum Disorder | Significant overlap | Neurodevelopmental | Distinct but frequently co-occurring |
| Bipolar Disorder | Up to 20% | Mood disorder | Mood stabilisers needed before stimulants |
| Tic Disorders / Tourette | Under 10% | Neurological | 60–80% of Tourette patients have ADHD |
| Sleep Disorders | 25–50% of children | Physical / sleep | Creates compounding negative cycle |
| Restless Leg Syndrome | Up to 33% of adults | Neurological / sleep | Shared dopamine dysregulation |
| Substance Use Disorders | Significantly elevated | Addiction | Treatment reduces risk |
| OCD | Notable overlap | Anxiety-related | Some ADHD treatments worsen OCD |
Diagnosing ADHD in the presence of co-occurring conditions, and vice versa, is one of the most challenging aspects of clinical assessment in this field. Symptoms overlap significantly, and conditions can mask each other, making it easy for a clinician to identify one condition and miss another entirely.
The American Academy of Pediatrics recommends that every child diagnosed with ADHD should be screened for other co-occurring disorders. The same principle applies in adult ADHD assessments, where a thorough evaluation should always include consideration of mood, anxiety, learning, sleep, and substance use alongside the core ADHD assessment.
Decisions about treatment priority depend on which condition is causing the most impairment in the individual's life. In many cases, clinicians elect to treat ADHD first because effective ADHD treatment can reduce stress, improve attentional and executive resources, and enhance the person's ability to engage with treatment for other conditions.
Our assessment covers 20 symptom domains including emotional regulation, sleep, social difficulties, anxiety patterns, hyperfocus, and childhood history, giving you a comprehensive picture of your attention profile that goes well beyond a simple ADHD checklist. Start your assessment for £2.99 →
Our 100-question assessment covers all 20 ADHD symptom domains including emotional dysregulation, anxiety patterns, sleep, and social difficulties. Get instant personalised results for just £2.99.
Start Your Assessment →At Attention Deficit Test, our ADHD resource library covers every aspect of ADHD, from understanding symptoms and types to navigating diagnosis, treatment, and related conditions.